CEREBELLAR INFARCTION side effect
What is CEREBELLAR INFARCTION ?Drugs associated with CEREBELLAR INFARCTION
ACTIVELLE ANGIOMAX COZAAR DECADRON DOCETAXEL ENBREL ETOPOSIDE EVISTA HUMIRA LUCENTIS LUPRON MYOZYME NICODERM NICOTINE NOVOSEVEN ORTHO REBIF STRATTERA VELCADE WARFARIN YASMIN ZOMIGCEREBELLAR INFARCTION : Decadron Side Effects Report #5661821-0
Physician from TURKEY reported DECADRON problem on Feb 18, 2008. Female patient, 52 years of age, was diagnosed with meningitis and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, cerebral ventricle dilatation, depressed level of consciousness, diabetic ketoacidosis, dysphagia, fatigue, gastrostomy, hemiparesis, mobility decreased, . DECADRON dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
CEREBELLAR INFARCTION : Humira Side Effects Report #5620564-X
HUMIRA problem was reported by a Consumer or non-health professional from GERMANY on Jan 30, 2008. Female patient, 76 years of age, was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, . HUMIRA dosage: unknown. During the same period patient was treated with LEFLUNOMIDE. Patient was hospitalized and became disabled. Patient recovered.
CEREBELLAR INFARCTION : Decadron Side Effects Report #5643070-5
Physician from TURKEY reported DECADRON problem on Feb 18, 2008. Female patient, 52 years of age, was diagnosed with meningitis and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, depressed level of consciousness, diabetic ketoacidosis, dilatation ventricular, dysphagia, fatigue, gastrostomy, hemiparesis, mobility decreased, . DECADRON dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
CEREBELLAR INFARCTION : Evista Side Effects Report #5608146-7
EVISTA problem was reported by a Physician from UNITED STATES on Jan 18, 2008. Female patient, weighting 120.0 lb, was diagnosed with osteoporosis and was treated with EVISTA. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, . EVISTA dosage: unknown. During the same period patient was treated with ASPIRIN, CALCIUM WITH VITAMIN D, PLAQUENIL. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Lucentis Side Effects Report #5545630-9
Consumer or non-health professional from UNITED STATES reported LUCENTIS problem on Dec 06, 2007. Female patient, weighting 140.0 lb, was treated with LUCENTIS. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, . LUCENTIS dosage: unknown. During the same period patient was treated with AVASTIN, XOPENEX, DIOVAN, CARDIZEM LA, ACTONEL, PLAQUENIL, SPIRIVA, XALATAN. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Activelle Side Effects Report #5528784-X
ACTIVELLE problem was reported by a Health Professional from SWEDEN on Nov 21, 2007. Female patient, 67 years of age, was treated with ACTIVELLE. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, . ACTIVELLE dosage: unknown. During the same period patient was treated with HERBAL PREPARATION, KALCIPOS, OMEPRAZOL, METFORMIN, METOTREXATE, PLENDIL. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Rebif Side Effects Report #5480895-3
Consumer or non-health professional from GERMANY reported REBIF problem on Sept 25, 2007. Female patient, 39 years of age, weighting 198.4 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, condition aggravated, dialysis, gastritis erosive, gastrointestinal haemorrhage, haemolysis, leukocytosis, multiple sclerosis, . REBIF dosage: unknown. During the same period patient was treated with MITOXANTRONE HYDROCHLORIDE. Patient was hospitalized and became disabled. Patient recovered.
CEREBELLAR INFARCTION : Zomig Side Effects Report #5500727-4
ZOMIG problem was reported by a Health Professional from FRANCE on Oct 18, 2007. Female patient was diagnosed with migraine, balance disorder and was treated with ZOMIG. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, cerebrovascular accident, . ZOMIG dosage: unknown. During the same period patient was treated with TANGANIL. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Lucentis Side Effects Report #5450287-1
Consumer or non-health professional from UNITED STATES reported LUCENTIS problem on Sept 06, 2007. Female patient, weighting 140.0 lb, was treated with LUCENTIS. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, . LUCENTIS dosage: unknown. During the same period patient was treated with AVASTIN, XOPENEX, DIOVAN, CARDIZEM LA, ACTONEL, PLAQUENIL, SPIRIVA, XALATAN. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Lucentis Side Effects Report #5450293-7
LUCENTIS problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 06, 2007. Female patient, weighting 140.0 lb, was treated with LUCENTIS. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, . LUCENTIS dosage: unknown. During the same period patient was treated with AVASTIN, XOPENEX, DIOVAN, CARDIZEM LA, ACTONEL, PLAQUENIL, SPIRIVA, XALATAN. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Novoseven Side Effects Report #5475682-6
Pharmacist from UNITED STATES reported NOVOSEVEN problem on Sept 28, 2007. Female patient, 60 years of age, weighting 220.0 lb, was diagnosed with haemostasis and was treated with NOVOSEVEN. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, depressed level of consciousness, troponin increased, . NOVOSEVEN dosage: unknown. Patient recovered.
CEREBELLAR INFARCTION : Warfarin Side Effects Report #5417934-1
WARFARIN problem was reported by a Consumer or non-health professional from on Aug 07, 2007. Male patient, 73 years of age, was diagnosed with atrial fibrillation and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, cerebral haemorrhage, cerebral infarction, pulmonary embolism, thrombosis, . WARFARIN dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, DILTIAZEM. Patient was hospitalized and became disabled. Patient recovered.
CEREBELLAR INFARCTION : Ortho Side Effects Report #5423580-6
Pharmacist from UNITED STATES reported ORTHO EVRA problem on Aug 21, 2007. Female patient, 27 years of age, was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, demyelination, dizziness, hypoaesthesia facial, ischaemia, visual disturbance, . ORTHO EVRA dosage: unknown. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Nicotine Side Effects Report #5444621-6
NICOTINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 17, 2007. Female patient, 40 years of age, was treated with NICOTINE. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, cerebrovascular spasm, . NICOTINE dosage: unknown. Patient recovered.
CEREBELLAR INFARCTION : Etoposide Side Effects Report #5385467-7
Health Professional from UNITED STATES reported ETOPOSIDE problem on July 11, 2007. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, febrile neutropenia, lung infection pseudomonal, renal failure acute, sepsis, supraventricular tachycardia, . ETOPOSIDE dosage: unknown. During the same period patient was treated with MITOXANTRONE, CYTARABINE. Patient was hospitalized. Patient died on 03/14/2007.
CEREBELLAR INFARCTION : Ortho Side Effects Report #5414556-3
ORTHO EVRA problem was reported by a Health Professional from UNITED STATES on May 08, 2007. Female patient, 37 years of age, weighting 165.0 lb, was diagnosed with contraception and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, . ORTHO EVRA dosage: unknown. During the same period patient was treated with ORTHO TRI, NEURONTIN, ALLEGRA, AMITRIPTYLINE, AMBIEN. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Ortho Side Effects Report #5414787-2
Health Professional from UNITED STATES reported ORTHO EVRA problem on May 14, 2007. Female patient, 37 years of age, was diagnosed with contraception and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, . ORTHO EVRA dosage: unknown. During the same period patient was treated with MAXALT. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Etoposide Side Effects Report #5385467-7
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on July 11, 2007. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, febrile neutropenia, lung infection pseudomonal, renal failure acute, sepsis, supraventricular tachycardia, . ETOPOSIDE dosage: unknown. During the same period patient was treated with MITOXANTRONE, CYTARABINE. Patient was hospitalized. Patient died on 03/14/2007.
CEREBELLAR INFARCTION : Ortho Side Effects Report #5414556-3
Health Professional from UNITED STATES reported ORTHO EVRA problem on May 08, 2007. Female patient, 37 years of age, weighting 165.0 lb, was diagnosed with contraception and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, . ORTHO EVRA dosage: unknown. During the same period patient was treated with ORTHO TRI, NEURONTIN, ALLEGRA, AMITRIPTYLINE, AMBIEN. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Ortho Side Effects Report #5414787-2
ORTHO EVRA problem was reported by a Health Professional from UNITED STATES on May 14, 2007. Female patient, 37 years of age, was diagnosed with contraception and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, . ORTHO EVRA dosage: unknown. During the same period patient was treated with MAXALT. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Cozaar Side Effects Report #5600752-9
Physician from CANADA reported COZAAR problem on Jan 18, 2008. Male patient, 65 years of age, was diagnosed with hypertension and was treated with COZAAR. After drug was administered, patient experienced the following problems/side effects: cellulitis, cerebellar infarction, . COZAAR dosage: unknown. During the same period patient was treated with ATENOLOL. Patient recovered.
CEREBELLAR INFARCTION : Ortho Side Effects Report #5525038-2
ORTHO EVRA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 16, 2007. Female patient, weighting 140.0 lb, was diagnosed with contraception, migraine and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: artery dissection, cerebellar infarction, coma, locked-in syndrome, pneumonia, respiratory failure, . ORTHO EVRA dosage: unknown. During the same period patient was treated with IMITREX. Patient was hospitalized and became disabled. Patient recovered.
CEREBELLAR INFARCTION : Velcade Side Effects Report #5485963-8
Physician from KOREA, REPUBLIC OF reported VELCADE problem on Sept 27, 2007. Male patient, 65 years of age, weighting 152.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: catheter sepsis, cerebellar infarction, dyspnoea, hypotension, pneumonia, reversible posterior leukoencephalopathy syndrome, . VELCADE dosage: 2.30 MG,. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE, VINCRISTINE, THALIDOMIDE. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Ortho Side Effects Report #5492202-0
ORTHO EVRA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 11, 2007. Female patient, weighting 140.0 lb, was diagnosed with contraception, migraine and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: artery dissection, cerebellar infarction, coma, locked-in syndrome, pneumonia, respiratory failure, . ORTHO EVRA dosage: unknown. During the same period patient was treated with IMITREX. Patient was hospitalized and became disabled. Patient recovered.
CEREBELLAR INFARCTION : Velcade Side Effects Report #5470353-4
Physician from KOREA, REPUBLIC OF reported VELCADE problem on Sept 10, 2007. Male patient, 65 years of age, weighting 152.1 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cerebellar infarction, cerebral infarction, pneumonia, sepsis, . VELCADE dosage: 2.30 MG. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE, VINCRISTINE, THALIDOMIDE. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Ortho Side Effects Report #5409543-5
ORTHO EVRA problem was reported by a Health Professional from UNITED STATES on Aug 02, 2007. Female patient, weighting 140.0 lb, was diagnosed with contraception, migraine and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: artery dissection, cerebellar infarction, coma, locked-in syndrome, pneumonia, respiratory failure, . ORTHO EVRA dosage: unknown. During the same period patient was treated with IMITREX. Patient was hospitalized and became disabled. Patient recovered.
CEREBELLAR INFARCTION : Ortho Side Effects Report #5429514-2
Health Professional from UNITED STATES reported ORTHO EVRA problem on Aug 24, 2007. Female patient, weighting 140.0 lb, was diagnosed with contraception, migraine and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: artery dissection, cerebellar infarction, coma, locked-in syndrome, pneumonia, respiratory failure, . ORTHO EVRA dosage: unknown. During the same period patient was treated with IMITREX. Patient was hospitalized and became disabled. Patient recovered.
CEREBELLAR INFARCTION : Ortho Side Effects Report #5436729-6
ORTHO EVRA problem was reported by a Health Professional from UNITED STATES on Aug 24, 2007. Female patient, weighting 140.0 lb, was diagnosed with contraception, migraine and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: artery dissection, cerebellar infarction, coma, locked-in syndrome, pneumonia, respiratory failure, . ORTHO EVRA dosage: unknown. During the same period patient was treated with IMITREX. Patient was hospitalized and became disabled. Patient recovered.
CEREBELLAR INFARCTION : Angiomax Side Effects Report #5392988-X
Physician from NORWAY reported ANGIOMAX problem on May 04, 2007. Male patient, 50 years of age, weighting 220.5 lb, was diagnosed with percutaneous coronary intervention, thrombosis and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: brain stem infarction, cerebellar infarction, . ANGIOMAX dosage: 75 MG, BOLUS, IV BOLUS, 175 MG, HR, INTRAVENOUS. During the same period patient was treated with EPTIFIBA. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Yasmin Side Effects Report #5393423-8
YASMIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2007. Female patient was treated with YASMIN. After drug was administered, patient experienced the following problems/side effects: asthenia, cerebellar infarction, cerebral infarction, dehydration, nausea, visual disturbance, visual field defect, vomiting, . YASMIN dosage: unknown. During the same period patient was treated with CLARITIN, LEXAPRO, ORTHO CYCLEN TRIPHASIC. Patient recovered.
CEREBELLAR INFARCTION : Strattera Side Effects Report #5395597-1
Consumer or non-health professional from reported STRATTERA problem on July 10, 2007. Male patient, child 12 years of age, was diagnosed with attention deficit/hyperactivity disorder, asthma and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: aphasia, cerebellar infarction, hemiplegia, . STRATTERA dosage: 40 MG, UNK. During the same period patient was treated with SINGULAIR. Patient was hospitalized and became disabled. Patient recovered.
CEREBELLAR INFARCTION : Lupron Side Effects Report #5397674-8
LUPRON problem was reported by a Physician from UNITED STATES on July 23, 2007. Female patient, 30 years of age, weighting 136.7 lb, was diagnosed with infertility female and was treated with LUPRON. After drug was administered, patient experienced the following problems/side effects: aphasia, cerebellar infarction, headache, transverse sinus thrombosis, visual disturbance, . LUPRON dosage: 0.25MG DAILY SQ. During the same period patient was treated with ORTHO CYCLEN. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Angiomax Side Effects Report #5392988-X
Physician from NORWAY reported ANGIOMAX problem on May 04, 2007. Male patient, 50 years of age, weighting 220.5 lb, was diagnosed with percutaneous coronary intervention, thrombosis and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: brain stem infarction, cerebellar infarction, . ANGIOMAX dosage: 75 MG, BOLUS, IV BOLUS, 175 MG, HR, INTRAVENOUS. During the same period patient was treated with EPTIFIBA. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Yasmin Side Effects Report #5393423-8
YASMIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2007. Female patient was treated with YASMIN. After drug was administered, patient experienced the following problems/side effects: asthenia, cerebellar infarction, cerebral infarction, dehydration, nausea, visual disturbance, visual field defect, vomiting, . YASMIN dosage: unknown. During the same period patient was treated with CLARITIN, LEXAPRO, ORTHO CYCLEN TRIPHASIC. Patient recovered.
CEREBELLAR INFARCTION : Strattera Side Effects Report #5395597-1
Consumer or non-health professional from reported STRATTERA problem on July 10, 2007. Male patient, child 12 years of age, was diagnosed with attention deficit/hyperactivity disorder, asthma and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: aphasia, cerebellar infarction, hemiplegia, . STRATTERA dosage: 40 MG, UNK. During the same period patient was treated with SINGULAIR. Patient was hospitalized and became disabled. Patient recovered.
CEREBELLAR INFARCTION : Lupron Side Effects Report #5397674-8
LUPRON problem was reported by a Physician from UNITED STATES on July 23, 2007. Female patient, 30 years of age, weighting 136.7 lb, was diagnosed with infertility female and was treated with LUPRON. After drug was administered, patient experienced the following problems/side effects: aphasia, cerebellar infarction, headache, transverse sinus thrombosis, visual disturbance, . LUPRON dosage: 0.25MG DAILY SQ. During the same period patient was treated with ORTHO CYCLEN. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Ortho Side Effects Report #5622018-3
Consumer or non-health professional from UNITED STATES reported ORTHO EVRA problem on Feb 01, 2008. Female patient, weighting 162.0 lb, was diagnosed with contraception, dizziness, headache and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: artery dissection, cerebellar atrophy, cerebellar infarction, cerebral infarction, cerebrovascular accident, . ORTHO EVRA dosage: unknown. During the same period patient was treated with NYQUIL, MECLIZINE, ADVIL. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Myozyme Side Effects Report #5644648-5
MYOZYME problem was reported by a Physician from UNITED STATES on Feb 13, 2008. Male patient, 19 years of age, was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: basilar artery thrombosis, brain stem infarction, cerebellar infarction, cerebrovascular accident, intracranial aneurysm, . MYOZYME dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient died on 09/16/2006.
CEREBELLAR INFARCTION : Enbrel Side Effects Report #5554821-2
Health Professional from SPAIN reported ENBREL problem on Nov 30, 2007. Male patient, 28 years of age, was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: aneurysm, aplasia, cerebellar infarction, . ENBREL dosage: unknown. Patient recovered.
CEREBELLAR INFARCTION : Docetaxel Side Effects Report #5512592-X
DOCETAXEL problem was reported by a Health Professional from UNITED STATES on Nov 06, 2007. Male patient, 65 years of age, weighting 140.0 lb, was treated with DOCETAXEL. After drug was administered, patient experienced the following problems/side effects: anaemia, atrial fibrillation, cerebellar infarction, dehydration, diarrhoea, fatigue, gastrointestinal haemorrhage, pneumonia, pulmonary alveolar haemorrhage, . DOCETAXEL dosage: DOSE: 62 MG AS TOTAL DOSE ADMINISTERED THIS COURSE. Patient was hospitalized. Patient recovered.
CEREBELLAR INFARCTION : Nicoderm Side Effects Report #5421520-7
Consumer or non-health professional from UNITED KINGDOM reported NICODERM CQ problem on Aug 03, 2007. Male patient, 52 years of age, was treated with NICODERM CQ. After drug was administered, patient experienced the following problems/side effects: blood triglycerides increased, cerebellar artery thrombosis, cerebellar infarction, low density lipoprotein increased, treatment noncompliance, . NICODERM CQ dosage: 21 MG TRANSDERMAL. Patient recovered.